Evoke Shares Skyrocket On New FDA Market Exclusivity For Gimoti Nasal Spray - Benzinga
Patheon To Manufacture FDA-Approved Nasal Spray | Contract Pharma
Eversana, Evoke Pharma partner on nasal drug
New Drug Product: Gimoti - MPR
Spray your symptoms away.
New metoclopramide nasal spray (Gimoti) can worsen Parkinson's: Tips on treating GI issues — Parkinson Secrets - Treatment Tips for PWP's & Caregivers -- ParkinsonSecrets.com
New Drug Product: Gimoti - MPR
NASDAQ: EVOK
Gimoti® (metoclopramide) nasal spray tools and resources
Gimoti® (metoclopramide) nasal spray
First-of-Its-Kind Nasal Spray Approved | RxWiki
Guide to Getting Your Prescription
Gimoti - FDA prescribing information, side effects and uses
Access to Gimoti® (metoclopramide) nasal spray
Approval [Rx ONLY]
FDA Approves Treatment for Recurrent Diabetes Gastroparesis
Gimoti® (metoclopramide) nasal spray
Discussion Guide | Gimoti® (metoclopramide) nasal spray
Evoke's experience with Thermo wins Patheon commercial Gimoti contract
Medical Policy
Gimoti® (metoclopramide) nasal spray pharmacokinetics
FDA Approves Gimoti Nasal Spray for Diabetic Gastroparesis - MPR
